Vimarsana
Biggest News Aggregation in the World

Page 8 - Repligen Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Repligen Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Repligen Daily Today - Breaking & Trending Today

Artisan Partners Limited Partnership Has $197.91 Million Stock Holdings in Repligen Co. (NASDAQ:RGEN) - Vimarsana News

Artisan Partners Limited Partnership Has $197.91 Million Stock Holdings in Repligen Co. (NASDAQ:RGEN)

Artisan Partners Limited Partnership lifted its holdings in Repligen Co. (NASDAQ:RGEN – Free Report) by 14.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,399,066 shares of the biotechnology company’s stock after purchasing an additional 177,485 shares during […]

Source: wkrb13.com
Insider Selling: Repligen Co. (NASDAQ:RGEN) Insider Sells 3,788 Shares of Stock - Vimarsana News

Insider Selling: Repligen Co. (NASDAQ:RGEN) Insider Sells 3,788 Shares of Stock

Repligen Co. (NASDAQ:RGEN – Get Free Report) insider Christine Gebski sold 3,788 shares of the stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $147.13, for a total transaction of $557,328.44. Following the transaction, the insider now owns 28,787 shares in the company, valued at […]

Royal Bank of Canada Lowers Repligen (NASDAQ:RGEN) Price Target to $200.00 - Vimarsana News

Royal Bank of Canada Lowers Repligen (NASDAQ:RGEN) Price Target to $200.00

Repligen (NASDAQ:RGEN – Free Report) had its price objective trimmed by Royal Bank of Canada from $207.00 to $200.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has an outperform rating on the biotechnology company’s stock. Other equities analysts have also issued research reports about the stock. Craig Hallum dropped […]

Source: wkrb13.com
New York State Common Retirement Fund Purchases 4,281 Shares of Repligen Co. (NASDAQ:RGEN) - Vimarsana News

New York State Common Retirement Fund Purchases 4,281 Shares of Repligen Co. (NASDAQ:RGEN)

New York State Common Retirement Fund boosted its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 1.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 436,799 shares of the biotechnology company’s stock after purchasing an additional 4,281 shares during […]

UBS Group Lowers Repligen (NASDAQ:RGEN) Price Target to $170.00 - Vimarsana News

UBS Group Lowers Repligen (NASDAQ:RGEN) Price Target to $170.00

Repligen (NASDAQ:RGEN – Get Free Report) had its price target dropped by investment analysts at UBS Group from $210.00 to $170.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. UBS Group’s target price suggests a potential upside of 24.51% from the stock’s […]

Source: wkrb13.com